The stock of Tectonic Therapeutic Inc (NASDAQ:TECX) last traded at $19.80, down -3.46% from the previous session.
TECX stock price is now -4.40% away from the 50-day moving average and -36.36% away from the 200-day moving average. The market capitalization of the company currently stands at $369.71M.
On April 21, 2025, Mizuho recently initiated its ‘Outperform’ rating on the stock quoting a target price of $51, while ‘Raymond James’ rates the stock as ‘Outperform’
In other news, SPRINGER TIMOTHY A, Director bought 53,706 shares of the company’s stock on Apr 11 ’25. The stock was bought for $875,945 at an average price of $16.31. Upon completion of the transaction, the Director now directly owns 1,503,358 shares in the company, valued at $29.77 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 10 ’25, Director SPRINGER TIMOTHY A bought 45,858 shares of the business’s stock. A total of $767,204 was incurred on buying the stock at an average price of $16.73. This leaves the insider owning 1,449,652 shares of the company worth $28.7 million. A total of 43.26% of the company’s stock is owned by insiders.
During the past 12 months, Tectonic Therapeutic Inc has had a low of $13.70 and a high of $61.07. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 22.92, and a quick ratio of 22.92.
The company reported revenue of $18.3 million for the quarter, compared to $12.97 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 41.1 percent.
